Jan 16 (Reuters) - Vaxart Inc VXRT.O :
* VAXART INC: ON JANUARY 12, AWARDED ASPR CONTRACT BY U.S.
GOVERNMENT
* VAXART:TO GET AWARD TO SUPPORT CLINICAL TRIAL PLANNING
ACTIVITIES FOR PHASE 2B CLINICAL TRIAL TO COMPARE CO'S XBB
VACCINE CANDIDATE TO MRNA COMPARATOR
* VAXART INC - ON JANUARY 15, ANDREI FLOROIU RESIGNED AS
PRESIDENT AND CHIEF EXECUTIVE OFFICER OF COMPANY
* VAXART INC - APPOINTMENT OF DR. FINNEY AS INTERIM CHIEF
EXECUTIVE OFFICER
* VAXART INC - CONDUCTING A SEARCH FOR FLOROIU'S SUCCESSOR
AS
CHIEF EXECUTIVE OFFICER
* VAXART INC -EFFECTIVE AS OF JAN 16, MICHAEL J. FINNEY,
BEEN
APPOINTED AS INTERIM CHIEF EXECUTIVE OFFICER OF THE COMPANY
Further company coverage: VXRT.O
(Reuters.Briefs@thomsonreuters.com)